18-47156242-GA-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_016097.5(IER3IP1):c.194-11del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000767 in 1,388,954 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00085 ( 0 hom. )
Consequence
IER3IP1
NM_016097.5 splice_polypyrimidine_tract, intron
NM_016097.5 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.679
Genes affected
IER3IP1 (HGNC:18550): (immediate early response 3 interacting protein 1) This gene encodes a small protein that is localized to the endoplasmic reticulum (ER) and may play a role in the ER stress response by mediating cell differentiation and apoptosis. Transcription of this gene is regulated by tumor necrosis factor alpha and specificity protein 1 (Sp1). Mutations in this gene may play a role in microcephaly, epilepsy, and diabetes syndrome (MEDS), and a pseudogene of this gene is located on the long arm of chromosome 12. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 18-47156242-GA-G is Benign according to our data. Variant chr18-47156242-GA-G is described in ClinVar as [Benign]. Clinvar id is 1598829.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IER3IP1 | NM_016097.5 | c.194-11del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000256433.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IER3IP1 | ENST00000256433.6 | c.194-11del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_016097.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000279 AC: 4AN: 143216Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
143216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000853 AC: 1062AN: 1245738Hom.: 0 Cov.: 22 AF XY: 0.000819 AC XY: 510AN XY: 622880
GnomAD4 exome
AF:
AC:
1062
AN:
1245738
Hom.:
Cov.:
22
AF XY:
AC XY:
510
AN XY:
622880
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000279 AC: 4AN: 143216Hom.: 0 Cov.: 32 AF XY: 0.0000288 AC XY: 2AN XY: 69430
GnomAD4 genome
AF:
AC:
4
AN:
143216
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
69430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Microcephaly, epilepsy, and diabetes syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at